Concert Pharmaceuticals, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €27.79M +312.3% -€70.45M +10.5% -253.5% +6.9 pp -€46.83M -20.2% -168.5% +7.0 pp
    €6.74M +633.7% -€63.77M -3.3% -946.2% +62 pp -€58.71M +43.2% -871.0% +36 pp
    €918.63K -89.7% -€65.96M +38.0% -7,180.0% -66 pp -€41.01M +6.5% -4,463.9% -40 pp
    €8.96M -92.7% -€47.79M -158.6% -533.3% -6.0 pp -€38.52M -143.5% -429.9% -5.0 pp
    €122.73M +82,596.0% €81.58M -288.6% 66.5% +290 pp €88.60M -333.0% 72.2% +260 pp
    €148.41K -99.7% -€43.26M -309.8% -29,149.4% -290 pp -€38.02M -286.3% -25,616.7% -260 pp
    €56.92M +678.1% €20.62M -176.3% 36.2% +4.1 pp €20.41M -182.6% 35.9% +3.7 pp
    €7.31M -66.2% -€27.04M +423.4% -369.6% -3.5 pp -€24.70M -316.4% -337.6% -3.9 pp
    €21.67M +97.7% -€5.17M -70.4% -23.8% +1.4 pp €11.41M -151.5% 52.7% +2.5 pp
    €10.96M -34.0% -€17.44M +80.6% -159.1% -1.0 pp -€22.14M +45.9% -202.0% -1.1 pp
    €16.60M -€9.66M -58.1% -€15.18M -91.4%

    Notifications